Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), Botnar Research Centre, Institute of Musculoskeletal Sciences, Nuffield Orthopaedic Centre, Windmill Road, Oxford OX3 7LD, UK.
Bone Joint Res. 2012 Jul 1;1(7):158-66. doi: 10.1302/2046-3758.17.2000115. Print 2012 Jul.
The pathogenesis of rotator cuff disease (RCD) is complex and not fully understood. This systematic review set out to summarise the histological and molecular changes that occur throughout the spectrum of RCD.
We conducted a systematic review of the scientific literature with specific inclusion and exclusion criteria.
A total of 101 studies met the inclusion criteria: 92 studies used human subjects exclusively, seven used animal overuse models, and the remaining two studies involved both humans and an animal overuse model. A total of 58 studies analysed supraspinatus tendon exclusively, 16 analysed subacromial bursal tissue exclusively, while the other studies analysed other tissue or varying combinations of tissue types including joint fluid and muscle. The molecular biomarkers that were altered in RCD included matrix substances, growth factors, enzymes and other proteins including certain neuropeptides.
The pathogenesis of RCD is being slowly unravelled as a result of the significant recent advances in molecular medicine. Future research aimed at further unlocking these key molecular processes will be pivotal in developing new surgical interventions both in terms of the diagnosis and treatment of RCD.
肩袖疾病(RCD)的发病机制复杂,尚未完全阐明。本系统综述旨在总结 RCD 各阶段发生的组织学和分子变化。
我们按照特定的纳入和排除标准对科学文献进行了系统综述。
共有 101 项研究符合纳入标准:92 项研究仅使用人类受试者,7 项研究使用动物过度使用模型,其余两项研究涉及人和动物过度使用模型。共有 58 项研究专门分析了肩袖肌腱,16 项研究专门分析了肩峰下滑囊组织,而其他研究则分析了其他组织或不同类型的组织组合,包括关节液和肌肉。在 RCD 中改变的分子生物标志物包括基质物质、生长因子、酶和其他蛋白质,包括某些神经肽。
由于分子医学的重大进展,RCD 的发病机制正在逐步揭示。未来旨在进一步揭示这些关键分子过程的研究对于开发新的手术干预措施将至关重要,无论是在 RCD 的诊断还是治疗方面。